軟骨寡聚基質蛋白(COMP)多克隆抗體
Polyclonal Antibody to Cartilage Oligomeric Matrix Protein (COMP)
MED; EDM1; EPD1; PSACH; THBS5; TSP-5; Pseudoachondroplasia,Epiphyseal Dysplasia 1,Multiple; Thrombospondin 5
- 編號PAB197Mu03
- 物種Mus musculus (Mouse,小鼠) 相同的名稱,不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPB197Mu03-軟骨寡聚基質蛋白(COMP)重組蛋白
- 緩沖液成份磷酸鹽緩沖液(pH7.4, 含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.)
- 性狀液體
- 濃度500μg/mL
- 且適物種Rattus norvegicus (Rat,大鼠)
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術,請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 518 ¥ 1210 ¥ 1728 ¥ 4320 ¥ 17280
- 欲了解實際交易價格和更多情況,請與當?shù)亟涗N商聯(lián)系!
特異性
該抗體是針對COMP的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別COMP。
用法
免疫印跡:0.2-2μg/mL;1:250-2500
免疫組織化學:5-20μg/mL;1:25-100
免疫細胞化學:5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務
相關產品
編號 | 適用物種:Mus musculus (Mouse,小鼠) | 應用(僅供研究使用,不用于臨床診斷!) |
RPB197Mu02 | 軟骨寡聚基質蛋白(COMP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB197Mu03 | 軟骨寡聚基質蛋白(COMP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB197Mu04 | 軟骨寡聚基質蛋白(COMP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB197Mu01 | 軟骨寡聚基質蛋白(COMP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB197Mu01 | 軟骨寡聚基質蛋白(COMP)多克隆抗體 | WB; IHC; ICC; IP. |
PAB197Mu04 | 軟骨寡聚基質蛋白(COMP)多克隆抗體 | WB; IHC; ICC; IP. |
PAB197Mu03 | 軟骨寡聚基質蛋白(COMP)多克隆抗體 | WB; IHC; ICC; IP. |
PAB197Mu02 | 軟骨寡聚基質蛋白(COMP)多克隆抗體 | WB; IHC; ICC; IP. |
LAB197Mu71 | 軟骨寡聚基質蛋白(COMP)多克隆抗體(生物素標記) | WB; IHC; ICC. |
MAB197Mu22 | 軟骨寡聚基質蛋白(COMP)單克隆抗體 | WB. |
MAB197Mu21 | 軟骨寡聚基質蛋白(COMP)單克隆抗體 | WB; IHC; ICC; IP. |
SEB197Mu | 軟骨寡聚基質蛋白(COMP)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB197Mu | 軟骨寡聚基質蛋白(COMP)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSB197Mu01 | 軟骨寡聚基質蛋白(COMP)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
Chinese Medical Journal | Genetic analysis and serum level of cartilage oligomeric matrix protein in patients with pseudoachondroplasia [CMJ: 201082337960590] |
BioMed Research International | Decreased Plasma COMP and Increased Plasma CTX-II Levels in a Chinese Pseudoachondroplasia Family with Novel COMP Mutation [pubmed:29104872] |
Molecular Medicine Reports | Mori Folium water extract alleviates articular cartilage damages and inflammatory responses in monosodium iodoacetate?induced osteoarthritis rats [pubmed:29067461] |
Archives of Rheumatology | Cartilage Oligomeric Matrix Protein Levels in Synovial Fluid in Patients With Primary Knee Osteoarthritis And Healthy Controls: A Preliminary Comparative Analysis With Serum Cartilage Oligomeric Matrix Protein [doi: 10.5606/ArchRheumatol.2017.6220] |
Genetic Testing and Molecular Biomarkers | Cartilage Oligomeric Matrix Protein Levels in Type 2 Diabetes Associated with Primary Knee Osteoarthritis Patients [Pubmed: 30526057] |
International Journal of Clinical and Experimental Medicine | The relationship between the serum and synovial fluid osteopontin (OPN), cartilage oligomeric matrix protein (COMP), and the severity of knee osteoarthritis … [] |
British Journal of Medicine and Medical Research | Diagnostic Accuracy of Cartilage Oligomeric Matrix Protein (COMP), for Cartilage Damage in Rheumatoid Arthritis [] |
留言咨詢